Amgen’s Kyprolis Meets Phase 3 Primary Goal

Amgen’s Kyprolis Meets Phase 3 Primary Goal

Amgen’s Phase 3 trial of Kyprolis was successful; patients’ progression-free survival increased

Amgen’s Kyprolis Meets Phase 3 Primary Goal

comments powered by Disqus